This article is
- freely available
RIG-I Like Receptors in Antiviral Immunity and Therapeutic Applications
Department of Immunology, University of Washington School of Medicine, Seattle, WA 98195, USA
* Author to whom correspondence should be addressed.
Received: 9 April 2011; in revised form: 4 June 2011 / Accepted: 9 June 2011 / Published: 23 June 2011
Abstract: The RNA helicase family of RIG-I-like receptors (RLRs) is a key component of host defense mechanisms responsible for detecting viruses and triggering innate immune signaling cascades to control viral replication and dissemination. As cytoplasm-based sensors, RLRs recognize foreign RNA in the cell and activate a cascade of antiviral responses including the induction of type I interferons, inflammasome activation, and expression of proinflammatory cytokines and chemokines. This review provides a brief overview of RLR function, ligand interactions, and downstream signaling events with an expanded discussion on the therapeutic potential of targeting RLRs for immune stimulation and treatment of virus infection.
Keywords: RIG-I; inflammation; adjuvant
Article StatisticsClick here to load and display the download statistics.
Notes: Multiple requests from the same IP address are counted as one view.
Cite This Article
MDPI and ACS Style
Ireton, R.C.; Gale Jr., M. RIG-I Like Receptors in Antiviral Immunity and Therapeutic Applications. Viruses 2011, 3, 906-919.
Ireton RC, Gale Jr. M. RIG-I Like Receptors in Antiviral Immunity and Therapeutic Applications. Viruses. 2011; 3(6):906-919.
Ireton, Reneé C.; Gale Jr., Michael. 2011. "RIG-I Like Receptors in Antiviral Immunity and Therapeutic Applications." Viruses 3, no. 6: 906-919.